Publication:
Leptin in nonalcoholic fatty liver disease

dc.contributor.authorsCanbakan, Billur; Tahan, Veysel; Balci, Huriye; Hatermi, Ibrahim; Erer, Burak; Ozbay, Gulsen; Sut, Necdet; Hacibekiroglu, Munire; Imeryuz, Nese; Senturk, Hakan
dc.date.accessioned2022-03-14T09:07:30Z
dc.date.accessioned2026-01-11T17:20:15Z
dc.date.available2022-03-14T09:07:30Z
dc.date.issued2008-07
dc.description.abstractBackground: Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition associated with obesity and insulin resistance (IR). Leptin plays a key role in the control of energy balance, and insulin sensitivity. In this study, we aimed to examine whether serum leptin levels correlate with insulin resistance, oxidative stress parameters and the severity of histological changes in NAFLD. Methods: Fifty-two patients (M/F: 28/24) with no alcohol intake and biopsy-proven diagnosis of NAFLD were studied. Serum leptin levels were measured by radioimmunoassay. HOMA (homeostasis model assessment) IR index was calculated. Comparisons between the patients with NAFLD and non-alcoholic steatohepatitis (NASH) were performed using the Student's t test. N-fultivariate regression analysis and the area under the receiver operating characteristic (ROC) curve were used to identify the independent predictors for NASH. Results: We found no association between serum leptin, fasting insulin levels, and oxidative stress parameters. ROC curve and multiple regression analysis revealed no association between the severity of histological changes and serum leptin levels. During six months followed-up period only NASH group with elevated leptin levels had significant reductions of ALT and AST values (p = 0.03, and 0.005, respectively). Conclusion: Our findings show a preventive effect of leptin against progressive liver injury in NAFLD.
dc.identifier.doi10.1016/S1665-2681(19)31856-3
dc.identifier.issn1665-2681
dc.identifier.pubmed18753993
dc.identifier.urihttps://hdl.handle.net/11424/242581
dc.identifier.wosWOS:000260006500009
dc.language.isoeng
dc.publisherELSEVIER ESPANA
dc.relation.ispartofANNALS OF HEPATOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectNon-alcoholic fatty liver disease
dc.subjectleptin
dc.subjectreactive oxygen species
dc.subjectinsulin resistance
dc.subjectNECROSIS-FACTOR-ALPHA
dc.subjectCOLLAGEN PRODUCTION
dc.subjectSTELLATE CELLS
dc.subjectSERUM LEPTIN
dc.subjectRECEPTOR
dc.subjectSTEATOHEPATITIS
dc.subjectFIBROSIS
dc.subjectOBESITY
dc.subjectIDENTIFICATION
dc.subjectSTEATOSIS
dc.titleLeptin in nonalcoholic fatty liver disease
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage254
oaire.citation.issue3
oaire.citation.startPage249
oaire.citation.titleANNALS OF HEPATOLOGY
oaire.citation.volume7

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
143.01 KB
Format:
Adobe Portable Document Format